Lawsuit accuses CDMO of ‘blocking’ COVID-19 vaccine
Inovio launches a lawsuit against VGXI, claiming that the CDMO has breached its manufacturing contract for vaccine candidate.
Inovio launches a lawsuit against VGXI, claiming that the CDMO has breached its manufacturing contract for vaccine candidate.
Paid for and content provided by Yourway
The ongoing pandemic has altered the face of human clinical trial execution, stimulating the adoption of decentralized/virtual trials. Here’s how to ensure success with your trial.